CLINICAL_TRIALS
trial_result
· 2022-09-23
Clinical Trial Update: Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial in boys with Duchenne muscular dystrophy has completed with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Catabasis Pharmaceuticals | Conditions: Muscular Dystrophy, Duchenne | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-09-23